Johnson and Johnson begins human safety trial for its COVID-19 vaccine candidate Ruchika Sharma1 Aug 2020 9:15 AM ISTUS: Johnson & Johnson on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys...
AstraZeneca reports strong drug sales in Q2 amid lockdown Ruchika Sharma31 July 2020 2:13 PM ISTNewer drugs for diabetes, heart conditions and cancer, including its top selling lung cancer drug Tagrisso, performed well in the quarter and...
Sanofi GSK to supply Britain with up to 60 million doses of a potential COVID-19 vaccine Ruchika Sharma30 July 2020 2:46 PM ISTBoth companies voiced in a statement their commitment " to making their COVID-19 vaccine candidate affordable and available globally".
EU talks with Pfizer, Sanofi, JnJ on Potential COVID Vaccines Struggle To Reach Deal: Report Ruchika Sharma29 July 2020 9:30 AM ISTMilan: European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment...
COVID-19 Vaccine: Serum Institute of India seeks DCGI nod for Phase 2/3 trials Ruchika Sharma27 July 2020 1:13 PM ISTThe domestic pharma giant has partnered with AstraZeneca for manufacturing the Oxford vaccine candidate for the highly infectious disease -- COVID-19.
COVID-19: First part of phase-1 of Covaxin human trial concluded with encouraging results Ruchika Sharma27 July 2020 12:20 PM ISTRohtak: The first part of phase-1 of Covaxin human trial completed on Saturday at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak, said Dr...
Independent scientists, ethicists charged for developing guidelines for distribution of eventual COVID-19 vaccine Ruchika Sharma27 July 2020 9:15 AM ISTChicago: U.S. public health officials on Friday charged a group of independent scientists and ethicists with developing guidelines to determine who...
Pfizer, BioNTech ink vaccine deal with US worth USD 2 billion Ruchika Sharma25 July 2020 9:15 AM ISTUnder the agreement, the US government has placed an initial order for 100 million doses to be delivered if regulatory approval is granted.
Covid-19 Vaccine: Draw up immunization strategy now itself, says Biocon Chief Kiran Mazumdar-Shaw Ruchika Sharma21 July 2020 2:43 PM ISTBengaluru: India needs to draw up its immunization strategy now itself on the administration of the vaccine for COVID-19 on the population when it...
COVID-19: Seven Indian Pharma firms in relay to develop vaccine Ruchika Sharma20 July 2020 12:34 PM ISTBharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms...
AIIMS starts human clinical trial of Covaxin from today Medical Dialogues Bureau20 July 2020 12:15 PM ISTCOVID-19 vaccine candidate Covaxin, developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of...
Oxford Covid-19 Vaccine Generates 'Double Defence', Shows Promise In Early Trial: Report Ruchika Sharma19 July 2020 9:15 AM ISTOxford scientists have found that the jab triggers a response that may offer a "double defense" against SARS-CoV-2, the virus that causes Covid-19,...
